- Design
- Retrospective cohort, national electronic health records (N3C)
- Population
- 60,980 adults with autoimmune rheumatic conditions and COVID-19, 2020–2024
- Primary outcome
- COVID-19-related hospitalisation
- Effect
- Booster aOR 0.29 (95% CI 0.27–0.31); updated vaccine aOR 0.31 (0.28–0.34) vs unvaccinated
A US national electronic records cohort identified 60,980 adults with autoimmune rheumatic conditions who developed COVID-19 between December 2020 and August 2024, and compared hospitalisation by vaccination status, adjusting for age, clinical risk, social vulnerability and medications.
Compared with no vaccination, the odds of hospitalisation were lower after the initial series (aOR 0.59), and lower still after a booster (aOR 0.29) or an updated 2023–24 vaccine (aOR 0.31). The absolute risk reduction for booster or updated vaccine over the initial series alone was 5.6 percentage points. Only 10% had received an updated vaccine.
This is observational, and people who get boosters may differ in ways that also protect them. But the gradient is consistent and the absolute difference is meaningful for immunosuppressed patients. It was published in September 2026.
- Recommend up-to-date COVID-19 vaccination for patients with autoimmune rheumatic disease.
- Check vaccination status at routine reviews, especially in those on immunosuppression.
- Uptake of updated vaccines was low in this cohort; ask rather than assume.
- Time vaccination around rituximab where possible to improve response.
Why it matters
Vaccine uptake falls with each round, yet protection in this group appeared to depend on staying current.
Don't overread it
People who choose boosters may differ from those who do not; this cannot show the full effect is due to the vaccine.
The statistics, in plain English
An adjusted odds ratio of 0.29 means about 70% lower odds of hospitalisation compared with the unvaccinated. The absolute risk reduction of 5.6 points means roughly one fewer hospitalisation for every 18 infected patients who had a booster rather than only the initial series.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for rheumatology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free